Introduction
============

Probiotics are live microorganisms, traditionally regarded as safe for human consumption that, when ingested in sufficient numbers, confer a health benefit to the host ([@B26], [@B26]). Probiotic microorganisms comprise mainly Gram-positive bacteria including LAB, bifidobacteria, enterococci, and propionibacteria. Some yeasts and Gram-negative bacteria may also be considered for probiotic use. Potential applications of probiotics involve the prevention and treatment of diarrhea caused by rotavirus, allergy and eczema, IBD; and the improvement of intestinal comfort, lactose intolerance, infection by *Helicobacter pylori*, and metabolic diseases ([@B97]; [@B24]). LAB constitute a large family of Gram-positive bacteria which are extensively implemented in the fermentation of a wide variety of food products. They include a variety of probiotic species: *Lactobacillus brevis*, *L. bulgaricus*, *L. plantarum*, *L. rhamnosus*, *L. casei*, *L. helveticus, L. salivarius*, *L. reuteri*, *L. johnsonii, L. fermentum*, and *L. acidophilus* ([@B3]). Propionibacteria, in particular *Propionibacterium freudenreichii* strains, are emergent probiotics, also used as ripening starter in Emmental cheese manufacturing, and as vitamins producers. These propionibacteria recently revealed potent beneficial effects, including the modulation of colon cancer cells proliferation and of colon inflammation ([@B81]). Several molecular mechanisms behind these probiotics' beneficial effects are being elucidated. They involve modulation of the gut microbiota composition, stimulation of the epithelial barrier function, and induction of immune responses ([@B60]; [@B81]). In addition, the role of bacterial surface compounds of Gram-positive bacteria includes the modulation of the gut immune system firstly, and then the systemic immune system, by mediating a cross-talk between the host and bacteria, whether they are commensals or probiotics. Such bacterial surface compounds constitute MAMPs; such as proteins, glycoproteins, lipoproteins, lipoteichoic acids, lipopolysaccharides and flagellins, which interact with the host PRRs, resulting in immune system modulation. Recently, several studies revealed the key role of surface-bound proteins, which are non-covalently attached to the cell wall, and are optionally present in certain probiotic bacteria. The surface-bound proteins may belong to a Slp lattice, an outermost macromolecular monolayer. First described in 1953 by Houwink, it consists of a paracrystalline bidimensional array made up of a Slp, which was first found on *Spirillum* sp. cell surface ([@B43]; [@B94]). Slps are extracted using chaotropic agents such as guanidine chloride and lithium chloride ([@B58]). These agents may also extract other proteins, either associated to the S-layer lattice, or anchored to the cell wall through non-covalent interaction domains. These proteins include CWBDs, lysin motif domain (LysM), GW modules or SLH domains ([@B17]). Several studies revealed the involvement of surface-bound proteins in the bacteria/host interaction, leading to beneficial effects such as immune modulation, but the molecular mechanisms are still not fully understood. Indeed, they fulfill various crucial functions in bacteria, such as contribution to determination or maintenance of cell shape, molecular sieve, enzyme activities, contribution to adhesion, coaggregation, modulation of gut immune cells, protection against environmental stresses and antimicrobial peptides ([@B45]). The purpose of this review is to discuss involvement of non-covalently surface-bound proteins in Gram-positive probiotics' functionalities and thus in their beneficial effects, and their future biotechnological applications.

Occurrence, Location, and Structure of S-Layer Proteins
=======================================================

S-Layer Proteins
----------------

S-layers are present in Archaea, Gram-positive and Gram-negative bacteria ([@B86], [@B87]), they exhibit a thickness of 5--25 nm ([@B86], [@B87]) and are highly porous ([@B86]; [@B91]). The S-layer paracrystalline lattice can be organized in different symmetry: oblique (p1, p2), tetragonal (p4), or hexagonal (p3, p6) symmetry ([@B67]; [@B90]; [@B91]; [@B76]). In Gram-positive bacteria, the S-layer lattice is generally composed of a single protein ([@B25]; [@B79]; [@B94]), and is attached to peptidoglycan-bound SCWPs by non-covalent interactions ([@B25]; [@B94]). The non-covalent anchorage of Slps may be mediated by different modules ([@B25]). Three SLH domains can fold into a pseudo-trimer and cooperate in the binding to SCWPs. This is the most widely distributed anchorage of Slps, found in many *Bacillus* species and in the probiotic *Propionibacterium freudenreichii* ([@B59]). Another conserved anchorage mechanism is mediated via three modules of cell-wall binding domain 2 (CWB2), found in many *Clostridium* species, and binding to cell wall compounds that are still not fully elucidated ([@B25]). By contrast, Slps from members of the *Lactobacillus* species are devoid of such motif and are anchored by a conserved CWBD, which can be C-terminal (*L. acidophilus*, *L. crispatus*) or N-terminal (*L. brevis*), while the opposite part of the protein, more variable, is involved in the self-assembly ([@B45]). The *L. acidophilus* SlpA C-terminal binding domain, which represents one-third of the protein, interacts with negatively charged SCWPs and with neutral polysaccharides ([@B94]).

Slps possess a molecular weight ranging from 25 to 200 kDa ([@B3]) and are typically rich in acidic and hydrophobic amino acids ([@B86], [@B87]; [@B91]; [@B79]), exhibiting a generally low isoelectric point (pI), with the exception of *Lactobacillus* Slps which have a high pI. In *P. freudenreichii*, five extractable surface proteins were identified using guanidine: SlpA, SlpB, SlpE, Internaline A (Inl A) and Large surface protein A (lsp A) ([@B59]; [@B18]). All these surface proteins are expressed quantitatively and qualitatively differently between different strains ([@B18]). However, only SlpA (illustrated in **Figure [1](#F1){ref-type="fig"}**) is considered as a true S-layer protein since its high expression level leads to the self-assembly of a SlpA-composed surface layer in *P. freudenreichii* strains CIRM-BIA 118 and CIRM-BIA 508 (alias CNRZ 722) ([@B67]; [@B16]). The SlpB protein, also presenting three SLH domains in its C-terminal domain (**Figure [2](#F2){ref-type="fig"}**), constitutes the major extractable surface protein in other *P. freudenreichii* strains, including CIRM BIA 129 ([@B59]). This suggests SlpB is a true S-layer protein, although the occurrence of a surface paracrystalline layer was not evidenced in these strains.

![Occurrence of an S-layer is strain-dependent in *Propionibacterium freudenreichii. P. freudenreichii* CIRM-BIA 118 is covered by an outermost surface layer **(A)** that is removed by extraction using the chaotropic agent guanidine **(B)**. Red arrows indicate the membrane (M), cell wall (CW), and S-layer (S). The CIRM-BIA 118 guanidine extract was analyzed by SDS-PAGE **(C)**, showing a major band close to 58 kDa corresponding to the S-layer protein A, as identified by MS/MS ([@B59]). Extracted SlpA was dialyzed against HEPES/NaCl buffer and deposited on mica and recrystallized prior to atomic force microscopy imaging ([@B16]). **(D)** Typical amplitude image obtained with purified Slp. **(E)** Close-up view of a Gaussian-filtered 40 nm × 40 nm phase image of recrystallized Slp showing a hexagonal arrangement. By contrast, *P. freudenreichii* CIRM-BIA 129 does not exhibit this S-layer (data not shown). However, extractable surface proteins **(C)**, in this strain, include Inl-like protein, 145 kDa, LspA (96 kDa), SlpE (59 kDa), SlpA (58 kDa), and SlpB (56 kDa). MM, molecular mass markers; WC, whole-cell SDS protein extract; ESP, extractable surface proteins guanidine extract.](fmicb-09-00645-g001){#F1}

![Predicted functional domains in *P. freudenreichii* extractable surface proteins. The functional domains were predicted using InterPro (EMBI/NCBI) for the five extractable surface proteins identified in different *P. freudenreichii* strains ([@B59]). S-layer protein A (SlpA), S-layer protein B (SlpB), S-layer protein E (SlpE) and Internaline-like (Inl-like) all exhibit three C-terminal conserved SLH domains allowing interaction with the peptidoglycan cell wall. By contrast, LspA exhibits no SLH domain, but *N*-acetylglucosaminidase-like domains suggesting a role in peptidoglycan metabolism.](fmicb-09-00645-g002){#F2}

Glycosylation is the major covalent modification observed in Slps from Gram-positive bacteria. It was previously reported in *L. kefiri* and *L. buchneri* ([@B76]). The glycosylation rate in Gram-positive bacteria Slps, leading to modification of 2--4 amino acid residues, is much lower than in Archaea. SlpB of *L. buchneri* shows four glycosylation sites consisting in *O*-glycosylation of seven glucose residues ([@B1]). Slps glycosylations may be *N*- or *O*-anchored to the peptide skeleton and consist in about 50 identical units containing neutral hexoses, pentoses, heptoses or deoxyhexose and amino sugars. The Slp of *L. kefiri* is O- and N-glycosylated, with 5-8 glucose units carrying galacturonic acid ([@B11]). Little is known about structure--function relationships of S-layer glycan moieties ([@B74]; [@B88]). These covalent modifications, however, may be critical for the cross-talk between bacteria carrying Slps and the host through PRRs, as demonstrated for *L. kefiri* ([@B78]).

Other Extractable Surface-Bound Proteins
----------------------------------------

Being non-covalently anchored to the cell wall, surface-bound proteins are extracted from intact bacteria by the action of chaotropic agents such as lithium chloride and guanidine chloride. Thus, bacterial strains that do possess a true S-layer are characterized by the fact that extraction leads to the isolation of one single molecular protein species, able to re-assemble into a characteristic lattice. However, a thorough proteomic study of this extracted fraction evidenced other proteins, in addition to Slps, in *L. acidophilus*, for example, showing that Slps constitute an anchor for several other extractable surface-bound proteins called SLAPs ([@B50]). Such proteins, identified in *Lactobacillus* species, have different functions, including interaction with the host ([@B50], [@B51], [@B52]; [@B107]; [@B110]). In the absence of an S-layer, other non-covalently surface-bound proteins may exist and be extracted using chaotropic agents. They present different anchorage domains including SLH domains ([@B17]).

Surface proteome analysis of many *P. freudenreichii* strains revealed the presence of two other proteins, SlpE and Inl-like, a protein showing homology with InlA (internalin A), which exhibit C-terminal SLH domains, with a lower level of expression (**Figures [1](#F1){ref-type="fig"}**, **[2](#F2){ref-type="fig"}**). They are detected in strains with or without a true SlpA surface-layer, suggesting that they are not true Slps. Regarding the protein lspA (large surface protein A), it is predicted to have a mannosyl-glycoprotein endo-beta-*N*-acetylglucosamidase-like domain and no SLH domain. Similarly, several reports further evidenced extractable surface-bound proteins in probiotic lactobacilli, and designated them as Slps, based on the presence of SLH domains, although these proteins were not shown to constitute a true paracrystalline thick surface layer. These last were, however, taken into consideration on the present review, provided that they play a role in probiotic/host interaction.

Probiotic--Host Interaction Via Extractable Surface Proteins
============================================================

The interaction between probiotic surface components and host cells may lead to modulation of gut functions ([@B101]). Commensal bacteria colonizing the gut have co-evolved with their host and developed molecular interaction mechanisms involved in adherence, epithelial barrier function and in immune system development ([@B108]; [@B105]). Therefore, immune cells and IECs are able to recognize several surface components (MAMPs) of autochthonous microbiota members, including lactobacilli and bifidobacteria, but also of allochthonous (food-borne) bacteria including lactobacilli, lactococci, and propionibacteria ([@B10]; [@B83]). The beneficial effect of probiotic bacteria, including activation of receptor-dependent pathways, is most probably favored by its ability to adhere to target cells. In this context, PRRs, including TLRs, expressed by enterocytes, are able to recognize MAMP, including extractable surface proteins.

Extractable Surface Proteins Are Involved in Adhesion to Epithelial Cells and Extracellular Matrix Proteins
-----------------------------------------------------------------------------------------------------------

In order to exert a beneficial effect on the host, probiotic bacteria must have the ability to tolerate digestive stresses and interact with host cells \[[@B29]\]. The adhesion of probiotic bacteria allows extending their persistence in the digestive tract, thus favoring a probiotic action. To understand how cell surface compounds from both partners can contribute to bacteria/cell adhesion, *in vitro* assays have been extensively used. This led to the development of recognized *in vitro* techniques ([@B5]; [@B104]). This includes the use of IECs lines such as Caco-2 ([@B41]) and HT-29 ([@B69]; [@B31]; [@B71]). Extracellular components are also used for adhesion, including laminin, fibronectin, collagen, and proteoglycan. Intestinal mucus, an extracellular matrix composed of large glycoproteins (mucins), water, electrolyte, produced by goblet cells, may also be used. Extracellular components are reported to play a major role in modulating adhesion of microorganisms to epithelial surface ([@B77]; [@B49]). Adhesion of probiotics to the gut mucosa may result in reduced colonization by pathogens, via competitive exclusion.

Several *in vitro* studies evidenced the involvement of extractable surface proteins, including Slps, in probiotic lactobacilli adhesion to mucus, and also to IECs. Gene inactivation of Slp genes was used in this purpose. Indeed, in *Lactobacillus acidophilus* NCFM, a knock-out mutant of the main S-layer protein, SlpA, evidenced its central role in adhesion to DCs and to their DC-SIGN receptors ([@B57]). Inactivation of this gene also leads to reduced adhesion to cultured IEC ([@B6]). In the same strain, a key role of several surface layer associated proteins in adhesion was confirmed when the mutation of AcmB (β-*N*-acetylglucosaminidase) ([@B51]), and of APF ([@B36]), led to a reduced binding to mucin, laminin and collagen and to IECs. By contrast, the deletion of the SLAP Serine Protease Homolog PrtX in *L. acidophilus* NCFM increases adhesion to mucin and fibronectin, which may result from the liberation of binding sites from the S-layer proteinaceous matrix ([@B52]). In *L. salivarius* REN, inactivation of cbpA, encoding a SLAP choline-binding protein A, showed reduced adhesion to cultured IEC ([@B106]). In other strains of *L. acidophilus*, the high expression of SlpA was correlated with a high capacity to adhere to Caco-2 cells ([@B2]). However, it was reported that mutation of *slp* genes have pleiotropic effects, including the loss of exposure of a variety of SLAPs, making it difficult to conclude the specific role of each protein species.

A role of Slps in adhesion was also suggested by investigations using extracted surface proteins. Indeed, surface extractable proteins from *L. acidophilus*, *L. brevis*, *L. helveticus*, and *L. kefiri* block DC-SIGN receptors *in vitro* and prevent adhesion of pathogenic bacteria to DC-SIGN expressing cells ([@B78]). Furthermore, lithium extraction of *L. acidophilus* fb214 surface proteins reduces adhesion to cultured IECs ([@B72]). In *L. acidophilus* NCFM, FbpB is a SLAP, showing a fibronectin-binding domain, which mediates adhesion to mucin and fibronectin *in vitro* ([@B44]). Accordingly, *L. brevis* ATCC 8287 surface layer shows a high affinity to laminin and to fibronectin, and its removal affects *L. brevis* adhesion to intestinal cells and to extracellular matrix proteins ([@B46]; [@B15]; [@B99]). Extracted surface bound proteins from probiotic lactobacilli were shown by different authors to bind *in vitro* to host cells proteins and extracellular matrix ([@B12]; [@B53]; [@B9]; [@B107]; [@B78]; [@B110]). However, such results should be considered with care, as Slps are poorly soluble, forming aggregates in aqueous environments, which renders interpretation of results difficult.

Adhesion to IECS and to mucus was also reported for dairy propionibacteria ([@B13]). Nonetheless, the adhesion rates were highly variable, depending on the adhesion model used, the strain and the growth conditions ([@B14]; [@B81]). A comparative study of *P. freudenreichii* strains, in terms of 1) adhesion rate and 2) surface proteome, led to the identification of propionibacterial SlpB as a potent adhesin, which was further confirmed by *slpb* gene inactivation ([@B19]). One protein, Inl-like (**Figure [2](#F2){ref-type="fig"}**) contains several leucine-rich repeats (LRRs), predicted to be involved in protein binding. It shows homologies with InlA, which functions as an adhesin in *Listeria monocytogenes*. However, no functional characterization was undertaken to study the role of this protein in *P. freudenreichii* adhesion. Furthermore; the S-layer protein A of *P. freudenreichii* is predicted to have an Immunoglobulin-like fold domain, found in some surface proteins in pathogen bacteria ([@B8]; [@B64]), where it is reported to play a role in adhesion to host cells.

The *in vitro* investigations reported here indicate a role of Slps and other associated proteins in adhesion to mucus components and to IECs, which is a prominent feature for probiotic bacteria to trigger beneficial effects within the gut mucosa. Nonetheless, *in vivo* studies are needed to confirm the role of Slps in adhesion, and thus in the persistence of probiotic bacteria within the gut. In addition, Slps-mediated adhesion to mucus and IECs is poorly understood, but is thought to lead to inhibition of pathogenic microorganisms adhesion ([@B45]; [@B94]).

Inhibition of Pathogens by Extractable Surface Proteins
-------------------------------------------------------

Inhibition of bacterial or viral infections is another beneficial application reported for probiotic bacteria, in which extractable surface proteins may play an important role. Indeed, adhesion of probiotic bacteria to the intestinal mucosa, via surface extractable adhesins interacting with host PRRs, may result in the inhibition of pathogens invasion by competitive exclusion. As an example, *L. helveticus* R0052 inhibits adhesion of entero-hemorrhagic *Escherichia coli* to caco-2 cells and so does its lithium surface proteins extract ([@B53]), which coaggregates with several pathogen species ([@B4]; [@B107]). In addition, Slps of *L. crispatus* ZJ001 ([@B12]), *L. kefir* ([@B37]), *L. salivarius*, and *L. reuteri* ([@B109]) were proposed to be responsible for competitive exclusion of bacterial pathogens such as *E. coli* and *Salmonella* species. A similar effect was shown for *L. acidophilus* Slps which inhibited adherence and invasion of Caco-2 cells by *Salmonella enterica* serovar Typhimurium ([@B61], [@B62]) and protected cells by restoring the transepithelial resistance. This resistance is a recognized marker of barrier integrity of tight junctions, in epithelial cell lines ([@B56]). These Slps inhibited the mitogen-activated protein kinase (MAPK) signaling pathways induced by *S. typhimurium* ([@B62]). In the same way, *L. plantarum* CGMCC 1258 MIMP protein, an extractable surface protein, limits pathogen invasion by inducing the expression of Claudin-1, Occludin, JAM-1, and ZO-1, by restoring tight junction damage and thus epithelium integrity ([@B80]; [@B65],[@B66]). Indeed, the intestinal mucosa tightness, relying on tight junctions (or "zonula occludens"), is impaired in several inflammatory and infections gut diseases ([@B102]; [@B89]).

A potential role of extractable surface proteins covering *L. acidophilus* ATCC4356, *L. brevis* ATCC14869, *L. helveticus* ATCC12046 or *L. kefiri* JCM5818 against bacterial infection of cells was observed ([@B78]). Cells expressing the DC-specific DC-SIGN receptor exhibited a reduced susceptibility to bacterial infections, as a result of pre-treatment with Lactobacilli Slps. Moreover, pre-treatment of the pathogens (both Gram-negative and mycobacterial models) with Slps from *L. acidophilus* ATCC 4356 and *L. brevis* ATCC 14869 reduces pathogens viability but also prevents infection ([@B78]). DC-SIGN is a CLR present in DCs and macrophages, it is involved in the recognition of several viruses and other microbes, a key step in the entry of pathogens into the cell. Indeed, *L. acidophilus* ATCC4356 Slps stimulate the activation of mouse DCs by activating IFN-I signaling pathway, which inhibit invasion of DCs by influenza virus H9N2 ([@B32]). In addition, *L. acidophilus* ATCC4356 Slps inhibit the Junin virus (JUNV) infection by interacting with DC-SIGN ([@B70]).

These data suggest a role of probiotics extractable surface proteins, including Slps, in the prevention of host colonization by pathogens responsible for infectious diarrhea. Once again, data obtained using extracted surface bound proteins should be considered with care and these hypotheses should be confirmed *in vivo*.

Immunomodulatory Properties of Extractable Surface Proteins
-----------------------------------------------------------

Selected strains of LAB, including *L. acidophilus*, and of PROPIONIBACTERIA, including *P. freudenreichii*, exert anti-inflammatory properties in the context of colitis, by modulating gut immunity. Intestinal homeostasis is tightly governed by regulatory immune mechanisms, which are established by interactions involving commensal/probiotic bacteria and host PRRs, including CLRs and TLRs. The disruption of such regulatory mechanisms may result in IBD. **Figure [3A](#F3){ref-type="fig"}** illustrates the cross-talk between probiotic bacteria and the host, mediated by IECs and immunes cells within the GALT, which initiates an immune responses according to the MAMPs recognized by various PRRs. This hypothetical schema is mainly based on *in vitro* investigations.

![Cross-talk between probiotic bacteria and the host, mediated by IECs and immunes cells, within the gut associated lymphoid tissues (GALT). **(A)** An overview of the interaction of antigen-presenting-cells such as DCs with probiotic bacterian, which initiates a tolerance response by inducing Treg/Th2 anti-inflammatory response; while DCs-pathogenic bacteria interaction induces a Th1/Th17 proinflammatory response. **(B)** S-layer proteins inhibit the proinflammatory response of epithelial cells by reducing NF-κB activity, which is induced by pathogenic bacteria; **(C)** S-layer proteins are recognized by DCs via DC-SIGN and TLR2 receptors, inducing tolerance response in the GALT. These hypothetical schemata are mainly based on *in vitro* investigations.](fmicb-09-00645-g003){#F3}

Detailed studies revealed the crucial role of Slps in host--probiotic interactions mediated by intestinal cells, which are an important protagonist at the forefront to maintain gut immunity homeostasis. *L. helveticus* MIMLh5 anti-inflammatory effects on Caco-2 cells is mediated by its SlpA and reduces activation of NF-κB ([@B98]). *L. acidophilus* contains three different Slps, SlpA, SlpB, and SlpX, which interact with PRRs and modulate the immune response. *L. acidophilus* Slps decrease interleukin (IL) 8 secretion in Caco-2 cells stimulated by *S. typhimurium* ([@B62]). IL-8 cytokine is an important proinflammatory mediator secreted by intestinal cells, as well as by activated macrophages, leading, in synergy with IL-12, to the development of T helper (Th1) cells in the intestinal mucosa ([@B85]). **Figure [3B](#F3){ref-type="fig"}** illustrates how probiotics, via the recognition of Slps, may reduce activation of NF-κB and therefore expression of IL8 in IECs, limiting the proinflammatory response induced by pathogen.

Besides the interaction with IECs, Slps interact with antigen-presenting cells such as DCs, which reside in the Peyer's patch, lamina propria and mesenteric lymph nodes. As schematized in **Figure [3A](#F3){ref-type="fig"}**, DCs are the main stimulators of naive T cells, which distinguishes them from all other antigen presenting cells. Depending on the microbial stimulus encountered, DCs promote the differentiation of naïve T cells toward Th1, Th2, unpolarized T cells, Th17 or T regulatory cell responses. Investigation of the role of *L. acidophilus* Slps provided insights into immune cells-Slps interactions and the resulting immune response within the gut. The high expression of SlpA in *L. acidophilus* L92 was correlated with high induction of IL-12p70 secretion during splenocytes stimulation ([@B2]). However, SlpA of *L. acidophilus* was reported to confer anti-inflammatory traits to the strain. Indeed, mutation of *L. acidophilus* NCFM SlpA results in a chromosomal inversion leading to dominant expression of SlpB. This mutant induces higher levels of proinflammatory cytokines such as IL-12p70, tumor necrosis factor-α (TNFα), and IL-1, compared to the wild-type strain, in DCs. However, both SlpA and SlpB activated TLR-2 at similar levels, an interaction that appeared to be crucial for the activating of IL-4-producing T cells ([@B57]). The protective role of SlpA in the context of colitis was further elucidated. *L. acidophilus* NCK2187, which solely expresses SlpA, and its purified SlpA, both bind to the C-type lectin SIGNR3 to induce regulatory signals that result in alleviation of colitis ([@B63]). However, such protection was not observed in Signr3-/- mice, suggesting that the SlpA/SIGNR3 interaction plays a key regulatory role in the healing of colitis ([@B63]). Other extractable surface proteins are involved in *L. acidophilus* NCFM immunomodulatory properties ([@B50], [@B52]). Indeed, mutation of the S-layer-associated serine protease homolog (Prtx) in *L. acidophilus* NCFM enhanced stimulation of IL-6, IL-12, and IL-10, compared to wild-type, when exposed to mouse DCs ([@B52]). The authors suggest that PrtX may degrade certain cytokines, so that amounts of cytokines are higher when using the mutant. Mutation of Lba-1029, a putative SLAP in *L. acidophilus* NCFM, revealed its role in a pro-inflammatory response in murine DCs, including TNFα secretion ([@B50]). SLAPs may thus take part in probiotics immunological properties. Slps of *L. helveticus* NS8, isolated from fermented koumiss, had no effect on the basal production of IL-10 in mouse macrophage cell line RAW264.7, but decreased IL12 expression triggered by LPS stimulation, suggesting an anti-inflammatory potential ([@B82]). Lactobacilli Slps contribute to the anti-inflammatory effect of probiotic bacteria within GALT, by interacting with DCs via different PRRs, which initiate the differentiation of Treg cells as illustrated by **Figure [3C](#F3){ref-type="fig"}**. Contrastingly, *L. helveticus* MIMLh5 and its SlpA act as stimulators of the innate immune system by triggering the expression of proinflammatory mediators such as TNFα and cyclooxygenase 2 (COX-2) in the human macrophage cell line U937 via TLR2 recognition ([@B98]). In the same experiments, this purified SlpA did not affect the expression of the anti-inflammatory cytokine interleukin-10 ([@B98]). Similarly, *L. brevis* Slps induce TNFα production in monocyte-derived dendritic cells (moDCs) ([@B99]).

Immunomodulation was also reported for PROPIONIBACTERIA. As an example, strain-dependent immunomodulatory properties were evidenced *in vitro* using human PBMCs ([@B27]; [@B18]) and then confirmed *in vivo* in a mouse colitis model ([@B28]). Extractable surface proteins were involved in this modulatory effect ([@B59]). Indeed, the extracted proteins induce regulatory IL-10, in a dose-dependent manner, in PBMCs, with little or no secretion of pro-inflammatory factors (IL-12, TNFα, and IL6) ([@B59]). In addition, they reduce the proinflammatory response triggered by the proinflammatory strain *Lactococcus lactis* MG1363 in PBMCs ([@B59]). Inactivation of the gene encoding SlpB suppress IL-10 induction by *P. freudenreichii*, and so does inactivation of SlpE ([@B18]). In the same time, expression of other surface proteins, including SlpF and moonlighting proteins, is also correlated with this anti-inflammatory trait in *P. freudenreichii*. By contrast, *P. freudenreichii* strains expressing high level of SlpA, a true S-layer protein, exert no immunomodulatory effect. The authors suggest that the immunomodulatory properties of *P. freudenreichii* strains result from a combination of several surface proteins ([@B18]). By contrast with lactobacilli, mechanisms involved in the interaction between PRRs and PROPIONIBACTERIA surface proteins remain unknown.

In conclusion, probiotic bacteria, via Slps, may have an immunomodulatory effect mediated by C-type lectin and TLR receptors within GALT. However, the effective role of these proteins should be confirmed *in vivo* in order to give tools to fight gut inflammation.

Protective Role of Probiotics' Extractable Surface Proteins
===========================================================

Bacterial surface layers are generally recognized as the outermost structure of the bacterial cell ([@B33]). They are thus widely considered to play a key role as an interface between intra- and extra-cellular compartments, and thus between the bacterium and its environment or its host. This interface was most likely developed as a consequence of the selective pressure generated by these interactions. They may act as a physical barrier against external factors ([@B92]), and also prevent the release of cellular molecules ([@B92]). Indeed, they are described as a molecular sieve, forming a highly porous structure with pores exhibiting identical morphology and size, within a bacterial strain, with some variations among strains. The porosity of this layer occupies a surface area that can go up to 70% ([@B93]; [@B3]). Studies on permeability have shown that some S-layers prevent the entry of molecules with molecular weights exceeding 10,000--15,000 kDa, providing the strain with a selective advantage ([@B67]).

The presence of surface layers was reportedly linked with enhanced tolerance toward stresses. Presence of an S-layer was reported to decrease *L. helveticus* susceptibility to mutanolysin ([@B68]). S-layers were furthermore shown to resist to extreme environmental conditions, even in extremophile bacteria, and to digestive assaults including variations in pH, bile salts, proteases and simulated gastrointestinal conditions ([@B96]; [@B12]; [@B23]). In accordance, coating of liposomes with S-layer proteins from *L. brevis* and from *L. kefiri* increased their stability upon exposure to bile salts, pancreatic extract and pH, as compared to uncoated liposomes ([@B42]). On the other hand, removal of Slps caused enhanced *L. hilgardii* susceptibility toward bacteriolytic enzymes and physicochemical stress ([@B21]). Furthermore, removal of the surface layer using the chaotropic agent lithium chloride drastically affects survival of *L. acidophilus* and of *L. helveticus* in simulated gastric and intestinal conditions ([@B30]; [@B72]). In accordance with a physiological role of S-layer proteins in defense mechanisms, their expression is induced by stimuli participating in digestive stress. In *L. acidophilus*, exposition to bile increases expression of SlpA in the ATCC 4356 strain ([@B55]). The same authors further evidenced similar induction of this protein by acidic pH and heat stress ([@B54]). Among bile constituents, bile salts were further evidenced as the stimuli responsible for S-layer induction in *L. acidophilus* IBB 8001 ([@B38]). The induction of Slps expression may thus take part in a general strategy to adapt and survive harsh environmental conditions encountered in the environment, in the digestive tract, or in the succession thereof ([@B7]; [@B33]). However, contrasting informations result from experimental gene inactivation of S-layer proteins in probiotic bacteria. Such mutations were indeed reported to drastically affect interactions with the host, including adhesion ([@B20]; [@B106]) and immune modulation ([@B57]; [@B18]). However, their impact on probiotics stress tolerance is still elusive. Deletion of the *slpa* gene caused alterations in cell envelope structure and defect in resistance to solvent and shear stresses in the environmental extremophilic bacterium *Deinococcus radiodurans* ([@B84]). In the probiotic *L. acidophilus*, the auxiliary S-layer protein SlpX, identified as a protein associated with the S-layer complex, plays a role in its permeability. Indeed, inactivation of SlpX affects the growth rate and the tolerance to bile salts in the NCK1962 mutant, as well as its relative overexpression in NCK1377, a SlpB-dominant strain that lacks SlpA protein. The NCK1962 slpX-negative mutant is more susceptible to SDS, yet more resistant to bile, than the wild type ([@B35]). Aggregation-promoting factors (Apf) are proteins considered as "S-layer-like" and identified at the surface of several lactobacilli. They share several characteristics with *Lactobacillus* S-layer proteins, such as their relative abundance on the cell surface, extractability by lithium chloride (LiCl), amino acid composition, predicted physical properties like high pI and indispensability for growth ([@B103]; [@B48]). Mutation of the corresponding *apf* gene in *L. acidophilus* resulted in enhanced susceptibility to SDS, to bile and to intestinal and gastric juices ([@B36]). This suggests reduced survival during transit through the digestive tract.

Finally, S-layers may also play a role in detoxification. The biosorption of toxic compounds, including uranium ([@B40]) and heavy metals ([@B100]) was reported for telluric bacteria belonging to the *Bacillus* species. It was attributed to their S-layers ([@B73]). Such heavy metal biosorption was later reported for *L. kefir* ([@B34]) with a key role of S-layer proteins. Biosorption of heavy metals and of mycotoxins was reported in *L. rhamnosus* and in *P. freudenreichii* ([@B47]; [@B39]). These last were shown in a clinical study to reduce the biologically effective dose of aflatoxin exposure and may thereby offer an effective dietary approach to decrease the risk of liver cancer ([@B22]).

Biotechnological Applications
=============================

The peculiar property of Slps to auto-assemble and to form reproducible supramolecular aggregates that are reputed irreversible and resistant to physicochemical assaults naturally led to the idea to use them in the field of (nano)biotechnology ([@B46]; [@B95]). Such monomolecular arrays provide well-defined structures, depending on the physicochemical properties of the glycoprotein, which constitutes the closed, isoporous lattice, and for which a wide biodiversity exists, among bacteria. This led to investigate the application of re-crystalized Slps to develop ultrafiltration membranes with very accurate molecular cutoffs, good stability afforded by intramolecular cross-linking, low membrane fouling and tunable surface properties in terms of net charges and hydrophilicity. Furthermore, chemical modifications and genetic engineering allow the immobilization of functional molecules, including enzymes, ligands, antigens and antibodies, while retaining the self-assembly properties of Slps. Some Slps being known to spontaneously produce preformed nanoparticles, on native surface-layers, functionalized Slps nanoparticles were made, including metallic and semiconductor nanoparticles. Other applications include Slps as supporting structures for functional lipid membranes, or for vaccine development. Indeed, conjugate vaccines with Slps and antigens, haptens or recombinant allergens, gave promising results in vaccination trials, due to intrinsic adjuvant properties of some SlpS. For a review on Slps biotechnological applications, se the review by [@B94].

Conclusion
==========

Extractable surface proteins, with various properties, have been described in several species and strains of probiotic bacteria. The peculiar properties of extractable surface proteins, including abundant expression, self-assembly, surface location, resistance to physicochemical assaults, immunomodulation, adhesion and toxic remediation, offer the possibility to orientate the biological properties of fermented food products and of probiotic food supplements. S-layer proteins have a great potential in the field of nanobiotechnology, because of their ability to form repetitive protein arrays by spontaneous association ([@B46]; [@B95]). This applies to vaccine candidates, to surface display of epitope, of proteins with therapeutic or biotechnologic interest ([@B75]). This opens promising perspectives in the field of gut disorders, including IBS and IBD, infectious diseases, as well as oral vaccination. Future trends include engineering of Slps for specific, efficient and cost-effective targeting of desired antigens and other medically important molecules.
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APF

:   aggregation-promoting-like factor

CLR

:   C-type lectin receptor

CWBD

:   cell wall binding domain

DC
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:   dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin
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SLAP

:   S-layer associated protein

SLH

:   S-layer homology domain
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:   surface-layer protein
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